Exponent, a private equity firm, completed the investment in Chanelle Pharma, a manufacturer of generic pharmaceuticals. Financial terms were not disclosed. “We are delighted to invest in Chanelle, a company we have admired for a long time. Our investment in Chanelle demonstrates our commitment to partner with market leading Irish businesses seeking to grow internationally and accelerate their growth. We look forward to working closely with Chanelle's management team to strengthen its global presence and invest in its capabilities. We applaud Michael’s leadership of the business and thank him for trusting us to take Chanelle forward," David McGovern, Exponent Partner.